ACM Research, Inc. reported strong second quarter 2026 results with 36% year-over-year revenue growth, driven by ECP and advanced packaging, and raise...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Take-Two reported Q1 sales below Street estimates due to minimal GTA VI impact, reaffirming its outlook given the game's push to 2025....
Institutional holdings report (13F-HR) filed by FTX Recovery Trust....
The company released its August 2026 investor presentation highlighting forward-looking statements regarding market risks and business strategy. The f...
Data systems company posted increased Q2 2026 net earnings and $2.24 EPS, with TDS Telecom raising its 2026 marketable fiber address guidance and Arra...
Array Digital Infrastructure reported second quarter 2026 results with record revenue and net income, narrowing revenue and raising Adjusted EBITDA gu...
Alpha Metallurgical Resources reported a Q2 2026 net loss of $12.3 million as high costs and reduced shipping volumes impacted results due to terminal...
Under Armour reported Q1 FY27 revenue of $1.1 billion, down 3%, while holding onto full-year profitability expectations. The company cited tariff refu...
Institutional holdings report (13F-HR) filed by Remedium Capital Partners, LLC....
E.W. Scripps reported a $1.2 billion per-share loss due to goodwill impairment. The company targets $125 million-150 million EBITDA growth by 2028 ami...
Institutional holdings report (13F-HR) filed by Board of the Pension Protection Fund....
Kimbell Royalty Partners announced record second quarter 2026 results, including a 15% increase in the cash distribution to $0.47 per unit. Alongside ...
Douglas Elliman Inc. reported a second quarter operating loss of $3.4 million on revenue of $283.4 million, marking a recovery from previous losses de...
Sylvamo released Q2 2026 results, generating a net loss of $11 million despite adjusted EBITDA of $60 million. The company announced a $0.45 dividend ...
Minerva Neurosciences provided an update on the confirmatory Phase 3 clinical trial of roluperidone for negative symptoms of schizophrenia, expecting ...
Treace Medical Concepts reported a 4% decline in second-quarter 2026 revenue to $45.4 million, demonstrating a reduction in sequential year-over-year ...
Embecta reported flat revenue guidance but raised adjusted operating margin and EPS targets for fiscal 2026. The results reflect challenges in U.S. ma...
The fast-food chain reported a 6.5% decline in global systemwide sales, cut its dividend, and withdrew its 2026 outlook as new leadership formulates a...
Canopy Growth reported net revenue growth of 13% and an adjusted EBITDA loss that narrowed 59% year-over-year in Q1 FY2027, driven by contributions fr...
Institutional holdings report (13F-HR) filed by SPRUCEGROVE INVESTMENT MANAGEMENT LTD....